(Q45851521)

English

Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis

scientific article published on 21 November 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22101198

Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22101198

1 reference

based on heuristic

inferred from title

Francesca Bonifazi

1

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22101198

object named as

M Stanzani

5

0 references

author name string

G Bandini

2

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22101198

M Arpinati

3

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22101198

G Tolomelli

4

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22101198

M R Motta

6

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22101198

S Rizzi

7

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22101198

V Giudice

8

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22101198

E Dan

9

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22101198

E Massari

10

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22101198

P Tazzari

11

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22101198

A Bontadini

12

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22101198

P Pagliaro

13

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22101198

M Baccarani

14

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22101198

language of work or name

0 references

publication date

21 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22101198

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22101198

47

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22101198

8

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22101198

1105-1111

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22101198

Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

21 January 2018

Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantat

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

21 January 2018

A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

21 January 2018

Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

21 January 2018

Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

21 January 2018

Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

21 January 2018

Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

21 January 2018

Quality of life associated with acute and chronic graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

21 January 2018

Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

21 January 2018

Peripheral blood progenitor cell or bone marrow transplantation: controversy remains

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

21 January 2018

Decision analysis of peripheral blood versus bone marrow hematopoietic stem cells for allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

21 January 2018

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

21 January 2018

Analysis of survival by tumor response.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

21 January 2018

Changes in the use of hematopoietic stem cell transplantation: a model for diffusion of medical technology

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

21 January 2018

Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

21 January 2018

Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

21 January 2018

Individual patient data meta-analysis of allogeneic peripheral blood stem cell transplant vs bone marrow transplant in the management of hematological malignancies: indirect assessment of the effect of day 11 methotrexate administration

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

21 January 2018

Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

21 January 2018

Allogeneic hematopoietic stem cell transplantation--yesterday, today, and tomorrow

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

21 January 2018

Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

21 January 2018

Sirolimus immunosuppression for graft-versus-host disease prophylaxis and therapy: an update

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

21 January 2018

A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft-versus-host disease prophylaxis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

21 January 2018

Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

21 January 2018

Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

21 January 2018

In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

21 January 2018

The EBMT activity survey 2008: impact of team size, team density and new trends

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

7 January 2021

based on heuristic

inferred from DOI database lookup

Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized multicenter comparison of CD34(+)-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-T-cell globulin: an essential ingredient for haematopoietic cell transplantation?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

7 January 2021

based on heuristic

inferred from DOI database lookup

Tacrolimus and mycofenolate mofetil as GvHD prophylaxis following nonmyeloablative conditioning and unrelated hematopoietic SCT for adult patients with advanced hematologic diseases

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of a novel specificity (CTLA-4) in ATG/TMG globulins and sera from ATG-treated leukemic patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.225

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/BMT.2011.225

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22101198

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22101198

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45851521&oldid=2207383501"